NASDAQ:ELOX

Eloxx Pharmaceuticals, Inc Earning Date

USA |NASDAQ |USD

ELOX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.13 $-0.54 $-0.16
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $0.00 $0.00 $0.00

Eloxx Pharmaceuticals, Inc's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

ELOX Earnings Date & History Chart

ELOX Earnings & Revenue Forecast

ELOX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.14 $-0.20 $-0.11
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-1.03 $-1.19 $-0.96
Dec 2022 4 $-0.57 $-0.88 $-0.41

ELOX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.14 $-0.13 $-0.13
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.03 $-0.59 $-0.59
Dec 2022 0 / 0 $-0.57 $-0.54 $-0.54

ELOX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $0.00 $0.00 $0.00
Dec 2022 4 $0.00 $0.00 $0.00

ELOX Earnings Date & Revenue History

ELOX Earnings History

|
Show More
Show More

ELOX Revenue History

|
Show More
Show More

Eloxx Pharmaceuticals, Inc Next Earnings Date & Report

ELOX Next Earnings Date & Report Preview: Sep 2021 (FQ)

ELOX's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Eloxx Pharmaceuticals, Inc's next quarterly earnings is $-0.13, with a low EPS estimation of $-0.20, and a high estimation of $-0.09.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.13, the last 2 month trend is $-0.12, and the 3 month trend is $-0.12.

Based on 4 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Eloxx Pharmaceuticals, Inc Previous Earnings Dates & Reports

ELOX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Eloxx Pharmaceuticals, Inc's previous earnings date was Aug 16, 2021 for its fiscal quarter ended Jun 30, 2021.

ELOX's earnings per share (EPS) was $-0.54, missing the consensus analysts forecast of $-0.14 by -292.73%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 145.45%, and lower than the same period a year before (Jun 2020) by 170.00%.

Revenues were $0.00.

The company reported a net income of $-36.06M.

Free cash flow for the quarter was $-9.80M , compared to $-7.68M last quarter and $-6.32M a year before.

ELOX ended the quarter with $11.20M in total debt, an increase of 4.00% compared to the previous quarter, and a decrease of -19.18% compared to the same quarter a year before.

ELOX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Eloxx Pharmaceuticals, Inc's previous annual earnings date was Mar 12, 2021 for its fiscal year ended Dec 31, 2020.

ELOX's earnings per share (EPS) was $-0.86, beating the consensus analysts forecast of $-0.92 by -6.52% , and higher than the previous year's EPS (Dec 2019) by -35.82%.

Revenues were $0.00.

The company reported a net income of $-34.58M.

Eloxx Pharmaceuticals, Inc reported a free cash flow of $-28.17M for its fiscal year, compared to $-39.43M a year ago.

The company ended the fiscal year with $10.87M in total debt, a decrease of -29.15% compared to the previous year.